Hepatitis B and C in institutions for individuals with intellectual disability

Journal of Intellectual Disability Research

Volumn 43, Issue 6, 1999, Pages 445-453

  Vellinga, A ^a   Van Damme, P ^a   Meheus, A ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Down's syndrome; Hepatitis B; Hepatitis C; Institutions

Indexed keywords

DOWN SYNDROME; HEPATITIS B; HEPATITIS C; HUMAN; INCIDENCE; INTELLECTUAL IMPAIRMENT; PREVALENCE; RESIDENTIAL HOME; REVIEW;

HEPATITIS ANTIGENS; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HOSPITALS, PSYCHIATRIC; HUMANS; INCIDENCE; INSTITUTIONALIZATION; MENTALLY DISABLED PERSONS; PREVALENCE; RESIDENTIAL FACILITIES; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; VIRAL HEPATITIS VACCINES; WORLD HEALTH;

EID: 0033457970     PISSN: 09642633     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2788.1999.00222.x     Document Type: Review

References (77)

1. Ahmän L., Back E., Bensch K. & Olcen P. (1993) Non-efficacy of low-dose intradermal vaccination against hepatitis B in Down's syndrome. Scandinavian Journal of Infectious Diseases 2, 16-23.
2. Arnedo Pena A., Latorre Ibánez M. D., Cortés Edo J. M., Pac Sa M. R., Querol Sanjuán J., González Morán F., Safont Adsuara L. & Hernández Martin R. (1995) Difusión de la hepatitis B entre los residentes de una institución para niños con minusvalías. Revista Espanda de Salud Pública 69, 219-26.
3. Arulrajan A. E., Tyrie C. M., Phillips K. & O'Connell S. (1992) Hepatitis B screening and immunization for people with a mental handicap in Southampton: costs and benefits. Journal of Intellectual Disability Research 36, 259-64.
4. Avanzini M. A., Monafo V., De Amici M., Maccario R. & Burgio G. R. (1990) Humoral immunodeficiencies in Down syndrome: serum IgG subclass and antibody response to hepatitis B vaccine. American Journal of Medical Genetics 7(Suppl.), 231-3.
5. Bakal C. W., Marr J. S., Novick L. F., Millner E. S., Goldman W. D. & Pitkin O. E. (1980) Deinstitutionalized mentally retarded hepatitis B surface antigen carriers in public school classes: a descriptive study. American Journal of Public Health 70, 709-11.
6. Bengoechea García M., Cortés A., Cabriada J., Albizu I., Dorronsoro M., Arriola J. A. & Arenas J. I. (1990) Respuesta a la vacuna DNA recombinada antihepatitis B en los deficientes mentales con sindrome de Down. Estudio controlado. Medicina Clinica (Barcelona) 94, 528-30.
7. Berenguer M. & Wright T. L. (1998) Hepatitis, Advances in antiviral therapy for hepatitis. Lancet 352, SIV15.
8. Boughton C. R., Hawkes R. A., Schroeter D. S. & Harlor J. (1976) The epidemiology of hepatitis B in a residential institution for the mentally retarded. Australian and New Zealand Journal of Medicine 6, 521-7.
9. Breuer B., Friedman S. M., Kane M. A., Snyder R. H. & Maynard J. E. (1985) Transmission of hepatitis B virus to classroom contacts of mentally retarded carriers. Journal of the American Medical Association 254, 3190-5.
10. Broggini M., Maggiolo F., Bianchie D. & Torre D. (1983) Study on the control of hepatitis B virus infection in an institution for the mentally retarded. Bollettino Dell Instituto Sieroterapico Milanese 62, 494-500.
11. Caballero Plasencia A. M., Avila Bullejos M., Bernal Zamora M. C., Zenner del Castillo G., de García los Arcos J. & Aliaga Montilla M. A. (1990) Viral A, B, C and D infections in an institution for the mentally retarded. (Letter.) Revista Espanola de Enfermedades Digestivas 78, 188-9.
12. Cancio-Bello T. P., de Medina M., Shorey J., Valledor M. D. & Schiff E. R. (1985) An institutional outbreak of hepatitis B related to a human biting carrier. Journal of Infectious Diseases 146, 652-6.
13. Carrascosa D., Ramirez V., De Casado A., La Torre R., Lopez-Fernandez E. & Saez J. (1997) Prevalence and significance of HBeAg and isolated anti-HBc in several institutions for the mentally retarded in the autonomous community of Madrid. American Journal of Human Biology 9, 29-33.
14. Centers for Disease Control. (1989) Guidelines for prevention of transmission of HIV and HBV to health care and public safety workers. Morbidity and Mortality Weekly Report 38, 3-37.
15. Chaudary R. K., Perry E., Hicks F., MacLean C. & Morbey M. (1992) Hepatitis B and C infection in an institution for the developmentally handicapped. New England Journal of Medicine 327, 1953.
16. Cramp M. E., Grundy H. C., Perinpanayagam R. M. & Barnado D. E. (1996) Seroprevalence of hepatitis B and C in two institutions caring for mentally handicapped adults. Journal of the Royal Society of Medicine 89, 401-2.
17. Cunningham S., Cunningham R., Izmeth M., Baker B. & Hart C. (1994) Seroprevalence of hepatitis B and C in a Merseyside hospital for the mentally handicapped. Epidemiology and Infection 112, 195-200.
18. Davis L. G., Weber D. J. & Lemon S. M. (1989) Horizontal transmission of hepatitis B virus. Lancet 8643, 889-93.
19. De Ponti F., Lecchini S., Cosentino M., Castelletti C. M., Malesci A. & Frigo G. M. (1993) Immunological adverse effects of anticonvulsants. What is their clinical relevance? Drug Safety 8, 235-50.
20. Devuyst O. & Maessen-Collard Y. (1991) Hepatitis B in a Belgian institution for mentally retarded patients: an epidemiological study. Acta Gastroenterologica Belgica 54, 12-18.
21. Di Ciommo V., Ferrario F., Rossi De Gasperi M., De Marchis C. & Albertini G. (1993) Epidemiology of hepatitis B virus in non-institutionalized children and adolescents affected by handicap. Journal of Intellectual Disability Research 37, 29-59.
22. Dicks J. & Dennis E. (1987) Down's syndrome and hepatitis: an evaluation of carrier status. The Journal of the American Dental Association 114, 637-9.
23. Dusheiko G. M., Smith M. & Scheier P. J. (1990) Hepatitis C virus transmitted by human bite. Lancet 336, 503-4.
24. Findor J. A., Sordá J. A., Rey J., Fernández J., Kohan A. & Díaz Lestrem M. (1992) Hepatitis B (HBV) and C (HCV) virus infections in Down's syndrome and in neuropsychiatric patients without Down's syndrome. GEN (Caracas) 46, 208-12.
25. Fried M. W., Shindo M., Fong T., Fox P. C., Hoofnagle J. H. & DiBisceglie A. M. (1992) Absence of hepatitis C viral RNA from saliva and semen of patients with chronic hepatitis C. Gastroenterol 102, 1306-8.
26. Garcia O., Bruguera M., Mayor A., Sanchez-Tapias J. M., Vall O. & Rodes J. (1990) Hepatitis B en una institución abierta para retrasados mentales. Efecto inmunogénico de una vacuna recombinante antihepatitis B. Enfermedades Infecciosas y Microbiologia Clinica 8, 148-52.
27. Grosheide P. & Van Damme P. (1996) Prevention and control of hepatitis B in the community. Communicable Disease Series, No. 1. Viral Hepatitis Prevention Board (Wilrijk, Belgium).
28. Hawkes R. A., Boughton C. R., Schroeter D. R., Decker R. H. & Overby R. L. (1980) Hepatitis B infection in institutionalized Down's syndrome inmates: a longitudinal study with five hepatitis B virus markers. Clinical and Experimental Immunology 40, 478-86.
29. Hayashi J., Kashiwagi S., Noguchi A., Nakashima K., Ikematsu H. & Kajiyama W. (1989) Intradermal hepatitis B vaccination for mentally retarded patients. Journal of Infection 19, 119-25.
30. Hayashi J., Kashiwagi S., Noguchi A., Nakashima K., Ikematsu H., Kajiyama W. & Nomura H. (1989) Hepatitis B virus infection among mentally retarded patients in institutions, Okinawa, Japan. Fukuoka Igaku Zasshi 80, 436-40.
31. Hayashi J., Kashiwagi S., Nomura H., Kajiyama W. & Ikematsu H. (1987) Hepatitis B virus transmission in nursery schools. American Journal of Epidemiology 125, 492-8.
32. Hayashi J., Nakashima K., Noguchi A., Morofuji M. & Kashiwagi S. (1991a) Cost-effectiveness of intradermal vs. subcutaneous hepatitis B vaccination for the mentally handicapped. Journal of Infection 23, 39-45.
33. Hayashi J., Noguchi A., Nakashima K, Morofuji M. & Kashiwagi S. (1991b) Long term observation of the effect of intradermal hepatitis B vaccination on mentally retarded patients. European Journal of Epidemiology 7, 649-53.
34. Heytinck R., De Jong P., Schalm S. & Masurel N. (1984) Hepatitis B vaccination in Down's syndrome and other mentally retarded patients. Hepatology 4, 611-14.
35. Isermann H. (1991) Häufigkeit von Hepatitis B bei geistig behinderten Heimbewohnern. Deutsche Medizinische Wochenschrift 116, 316.
36. Jenison S. A., Lemon S. M., Baker L. N. & Newbold J. E. (1987) Quantitative analysis of hepatitis B virus DNA in saliva and semen of chronically infected homosexual men. Journal of Infectious Diseases 156, 299-307.
37. Jover Ibarra J. & Ramírez Marín V. (1989) Distribution of hepatitis B virus in a center for the psychologically handicapped in Madrid. Risk indicators. Revista de Sanidad e Higiene Publica (Madrid) 63, 111-18.
38. Leonard J., Holtgrave D. R. & Johnson R. (1991) Cost-effectiveness of hepatitis B screening in a mental health institute. Journal of Family Practice 32, 45-8.
39. Levinson W. M., Wormser G. P., Forseter G., Calmann M. & O'Brien T. A. (1992) Hepatitis C virus seroprevalence in the developmentally disabled. Archives of Internal Medicine 152, 2309-11.
40. Lohiya S., Lohiya G. & Caires S. (1986) Epidemiology of hepatitis B infection in institutionalized mentally retarded clients. American Journal of Public Health 76, 799-802.
41. Mann J. M., Kane M. H. & Hull F. (1983) Hepatitis B, hepatitis B vaccine and education for the handicapped. Pediatic Infectious Diseases 2, 273-5.
42. Marena C., Bignamini A., Meloni F., Mastretti A., Agnusdei A. & Pelissero G. (1996) Seroprevalence of hepatitis B virus markers and risk factors in patients and staff of an Italian residential institution for the mentally disabled. Journal of Clinical Epidemiology 49, 1009-12.
43. Marr J. S., Beck A. M. & Lugo J. A. (1979) Epidemiologic study of the human bite. Public Health Report 94, 346-9.
44. Martinez J. L., del Hierro J., Camarero A., Medarde A., Lopez M. T. & Latasa J. (1991) Estudio de la infección por virus de la hepatitis C en differentes grupos de riesgo y en donantes de sangre. Enfermedades Infecciosas y Microbiologia Clinica 9, 345-50.
45. May P. & Kawanishi H. (1996) Chronic hepatitis B infection and autoimmune thyroiditis in Down syndrome. Journal of Clinical Gastroenterology 23, 181-4.
46. Mölsä P. K. (1990) Hepatitis B carriers in a centre for the mentally retarded in Finland and immunogenicity of hepatitis B vaccine. Journal of Mental Deficiency Research 34, 379-83.
47. Mortimer P. P., Cohen B. J., Litton P. A., Vandervelde E. M., Bassendine M. F., Brind A. M. & Hambling M. H. (1989) Hepatitis C virus antibody. Lancet, 798.
48. Murphy M. & Epstein L. B. (1992) Down Syndrome (DS) peripheral blood contains phenotypically mature CD3+TCR alpha, beta+ cells but abnormal proportions of TCR alpha, beta+, TCR gamma, delta+ and CD4+ CD45RA+ cells: evidence for an inefficient release of mature T cells by the DS thymus. Clinical Immunology and Immunopathology 62, 245-51.
49. Nespoli L., Burgio G. R., Ugazio A. G. & Maccario R. (1993) Immunologic features of Down's syndrome: a review. Journal of Intellectual Disability Research 37, 543-51.
50. Perrillo R. P., Storch G. A., Bodicky C. J., Campbell C. R. & Sanders G. E. (1984) Survey of hepatitis B viral markers at a public day school and a residential institution sharing mentally handicapped students. Journal of Infectious Diseases 149, 796-800.
51. Perrillo R. P., Strang R. P. & Lowry O. H. (1986) Different operating conditions affect risk of hepatitis B virus infection at two residential institutions for the mentally disabled. American Journal of Epidemiology 123, 690-8.
52. Piccione M., Curtis M., La Vecchia M. L., Novissimo A. & Vajro P. (1997) Hepatitis B and C infection in children with Down syndrome. European Journal of Pediatrics 156, 420-1.
53. Pregliasco F. & Conti A. (1994) Prevalence of anti-HCV in institutionalised mentally handicapped subjects. European Journal of Epidemiology 10, 113-14.
54. Pueschel S. M., Bodenheimer H. C., Giesswein P. & Dean M. K. (1991) The prevalence of hepatitis B surface antigen and antibody in home-reared individuals with Down syndrome. Research in Developmental Disabilities 12, 243-9.
55. Quer J. & Esteban J. I. (1997) Epidemiology and prevention of hepatitis C virus infection. In: Hepatitis C 1997: Essays and expert opinions on its natural history, epidemiology, diagnosis and therapy (eds R. Decker & H. Troonen), pp. 26-38. Abott Diagnostics Educational Series, Germany.
56. Reniers J., Vranckx R., Heremans G., Van Damme P. & Meheus A. (1986) Age and immune response to hepatitis B vaccine in mentally handicapped. Archives of the Belgian Medical Society 44, 489-93.
57. Rua Armesto M. J., Ramírez Marín V., Onaindia Ercoreca M. T., García Aguado J. & Ruiz Moreno M. (1993) Predisposition of Down's syndrome to chronic infection with the hepatitis B virus. Anales Espanola de Pediatria 38, 529-31.
58. Schoub B. D., Johnson S., McAnerney J. M. & Blackburn N. K. (1993) Hepatitis B virus prevalence in two institutions for the mentally handicapped. South African Medical Journal 83, 650-3.
59. Scull D. & Coope B. (1996) Response to vaccination in a mental handicap hospital. Journal of Intellectual Disability Research 40, 484-6.
60. Shapiro C. N., McCaig L. F., Gensheimer K. F., Levy M. E., Stoddard J. J., Kane M. A. & Hadler S. C. (1989) Hepatitis B virus transmission between children in day care. Pediatric Infectious Disease Journal 8, 870-5.
61. Stehr Green P., Wildon N., Miller J. & Lawther A. (1991) Risk factors for hepatitis B at a residential institution for mentally handicapped persons. New Zealand Medical Journal 104, 514-6.
62. Szmuness W., Neurath A. R., Stevens C. E., Strick N. & Harley E. J. (1981) Prevalence of hepatitis B e antigen and its antibody in various HBsAg carrier populations. American Journal of Epidemiology 113, 113-21.
63. Tiku M. L., Beutner K. R., Carmody P., Sultz M. A., Kaul B. L. & Ogra P. L. (1976) Hepatitis B infection in healthy care personnel of an institution for mentally handicapped children and adults. Journal of Clinical Microbiology 3, 469-73.
64. Torre D., Giola M., Zeroli C., Ferrario G., Broggini M., Agrifoglio L. & Botta V. (1993) Hepatitis B and C infection in an institution for the mentally handicapped. Infection 21, 410.
65. Ugazio A. G., Jayakar S. D., Marcioni A. F., Duse M., Monafo V., Pasquali F. & Burgio G. R. (1977) Immunodeficiency in Down's syndrome: relationship between presence of human thyroglobulin antibodies and HBsAg carrier status. European Journal of Pediatrics 126, 139-46.
66. Vajro P., Lettera P., Fontanella A., Sbreglia C., Manzillo E., Sartorio R. & Del Giudice E. (1992) Vaccination against hepatitis B in preschool children with Down's syndrome. Journal of Intellectual Disability Research 36, 77-81.
67. Van Damme P., Kane M. & Meheus A. (1997) Integration of hepatitis B vaccination into national immunisation programmes. British Medical Journal 314, 1033-7.
68. Van Damme P. & Meheus A. (1989) Hepatitis B and Down's syndrome. (Letter.) Lancet, 840-1.
69. Van Damme P. & Vellinga A. (1998) Epidemiology of hepatitis B and C in Europe. Acta Gastroenterologica Belgica 61, 175-82.
70. Van Damme P., Vranckx R. & Meheus A. (1990) Immunogenicity of a recombinant DNA hepatitis B vaccine in institutionalized patients with Down's syndrome. Vaccine 8, 53-5.
71. Van Damme P., Vranckx R., Safary A. & Meheus A. (1989) Protective efficacy of a recombinant deoxyribonucleic acid hepatitis B vaccine in institutionalized mentally handicapped clients. American Journal of Medicine 87, 26-9.
72. Van Ditzhuysen Th., De Witte A., Van Loon A. M., Rijntjes P. & Yap S. (1988) Hepatitis B virus in an institution for the mentally retarded. American Journal of Epidemiology 128, 629-38.
73. Vento S., Garafano T., Renzini C., Cainelli F., Caseli F., Ghironzi G., Ferraro T. & Concia E. (1998) Fulminant hepatitis associated with hepatitis A superinfection in patients with chronic hepatitis C. New England Journal of Medicine 338, 286-90.
74. Vermeltfoort J. A. (1991) Re-vaccination against hepatitis B of non- and hyporesponders in a group of mentally handicapped persons. Nederlands Tijdschrift Voor Geneeskunde 135, 217-35. (In Dutch.)
75. Vranckx R. & Van Damme P. (1990) Hepatitis C in institutionalized children. New England Journal of Medicine 323, 64.
76. Wahl M., Hermodsson S. & Iwarson S. (1983) Immune responses to hepatitis B vaccine in the mentally retarded. Journal of Infection 7, 47-51.
77. West D. J., Snavely D. B., Zajac B. Z., Brown G. W. & Babb C. J. (1990) Development and persistence of antibody in a high risk institutionalized population given plasma-derived hepatitis B vaccine. Vaccine 8, 111-14.